Skip to main content

Geographic Atrophy - Test Your Knowledge 360

Release Date: March 7, 2024
Expiration Date: March 7, 2025

Note: Please review the frontmatter below and scroll to the bottom to continue to the course

Activity Overview

In this text-based activity, learners will answer multiple-choice questions about diverse topics in GA, which may include risk factors, quality-of-life issues, diagnosis and ongoing monitoring, FDA-approved treatments (eg, prescribing, mechanism of action, study data [efficacy, safety]), emerging treatments and interprofessional care.

Target Audience

This activity is designed for ophthalmologists, retina specialists, optometrists, and other healthcare professionals involved in the care of patients with GA.

Learning Objectives

Upon completion of the educational activity, participants should be able to:
  • Identify risk factors for GA
  • Describe current treatment approaches for GA

Criteria for Success

To obtain a certificate of completion, a score of 70% or better on the post-test is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your certificate. You must participate in the entire activity to receive credit. There is no fee to participate in this activity. If you have questions about this activity, please contact AKH Inc. at

CE credit provided by AKH Inc., Advancing Knowledge in Healthcare

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and International Healthcare Media, LLC. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of .25 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

COPE - Optometrists

AKH Inc., Advancing Knowledge in Healthcare designates this asynchronous activity for a maximum of .25 COPE credit hours. Optometrists should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support

This activity is supported by independent educational grants from Iveric Bio inc.
Name Relationship Commercial Interest
Nadia Waheed MD, MPH (faculty) Consultant Nidek, Zeiss, Topcon, Ocudyne, Stealth, Novartis, Complement Therapeutics, Saliogen, Valitor, Olix
Employee AGTC
Dorothy Caputo, MA, BSN, RN - VP, Healthcare Continuing Education and Operations N/A Nothing to disclose
Michele Bielarski, RN (planner/reviewer) N/A Nothing to disclose
AKH Inc Staff and Planners N/A Nothing to disclose
International Healthcare Media bda International Healthcare Education Staff and Planners N/A Nothing to disclose


It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose. If you would like to opt out from future communications from AKH please send an email to with your information with "Opt Out" in the subject line.

Disclosure of Unlabeled Use and Investigational Product

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content.